GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Innocan Pharma INNO.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

1.82

—

Close of 5 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Innocan Pharma — daily INNO

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Innocan Pharma on TradingView ↗
Market value
C$8.2m
Last close × shares
Volume
1.3k
Shares, 5 Nov 2026

About Innocan Pharma

Its shares trade on Canadian Securities Exchange under the ticker INNO.CN. It has been listed since 24 September 2019. In the fiscal year to 31 December 2024, it reported revenue of $29.4m and a net loss of $1.8m. At that date it held total assets of $9.3m and shareholders' equity of $5.2m.

InnoCan Pharma Corp. operates as a pharmaceutical tech company. The company operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. The firm is developing an OTC topical treatments product line and new platform to facilitate the targeted controlled administration of cannabinoids via injection.

Figures and description from our data supplier, not checked against the company's own report.

More about Innocan Pharma →

Latest on Innocan Pharma

Our reporting

We have not reported on Innocan Pharma yet.

Next results

25 Nov 2026

Due on 25 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Innocan Pharma's ticker?

Innocan Pharma trades as INNO.CN on Canadian Securities Exchange, under ISIN CA45783P5085.

What was Innocan Pharma's last closing price?

1.82 on 5 Nov 2026. The figure is in CAD and is never converted.

When does Innocan Pharma next report results?

Results are expected on 25 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.